QUIDEL CORP /DE/ Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in QUIDEL CORP /DE/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in QUIDEL CORP /DE/ for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 59.12 | 3,926 | 232,105 | 3,924 | |
| Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 47.85 | 2,970 | 142,115 | 0 | |
| Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 46.41 | 2,303 | 106,882 | 2,303 | |
| Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 21.08 | 3,585 | 75,572 | 0 | |
| Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Sell | S | 173.71 | 5,283 | 917,734 | 8,119 | 13.4 K to 8.1 K (-39.42 %) |
| Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Sell | S | 164.59 | 173 | 28,474 | 13,402 | 13.6 K to 13.4 K (-1.27 %) |
| Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Sell | S | 166.36 | 4,662 | 775,584 | 13,575 | 18.2 K to 13.6 K (-25.56 %) |
| Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Sell | S | 164.11 | 12,784 | 2,097,955 | 18,237 | 31 K to 18.2 K (-41.21 %) |
| Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Buy | M | 59.12 | 3,926 | 232,105 | 31,021 | 27.1 K to 31 K (+14.49 %) |
| Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Buy | M | 47.85 | 2,970 | 142,115 | 27,095 | 24.1 K to 27.1 K (+12.31 %) |
| Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Buy | M | 46.41 | 2,303 | 106,882 | 24,125 | 21.8 K to 24.1 K (+10.55 %) |
| Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Buy | M | 21.08 | 3,585 | 75,572 | 21,822 | 18.2 K to 21.8 K (+19.66 %) |
| Feb 22 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Buy | P | 165.30 | 5,000 | 826,500 | 495,807 | 490.8 K to 495.8 K (+1.02 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Payment of Exercise | F | 210.10 | 1,797 | 377,550 | 26,126 | 27.9 K to 26.1 K (-6.44 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Grant | A | 0.00 | 3,623 | 0 | 27,923 | 24.3 K to 27.9 K (+14.91 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Payment of Exercise | F | 210.10 | 2,284 | 479,868 | 24,300 | 26.6 K to 24.3 K (-8.59 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Grant | A | 0.00 | 4,606 | 0 | 26,584 | 22 K to 26.6 K (+20.96 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Payment of Exercise | F | 210.10 | 585 | 122,909 | 12,063 | 12.6 K to 12.1 K (-4.63 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Grant | A | 0.00 | 1,510 | 0 | 12,648 | 11.1 K to 12.6 K (+13.56 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Payment of Exercise | F | 210.10 | 421 | 88,452 | 11,138 | 11.6 K to 11.1 K (-3.64 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Grant | A | 0.00 | 1,727 | 0 | 11,559 | 9.8 K to 11.6 K (+17.57 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 0.00 | 1,055 | 0 | 0 | |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 0.00 | 3,519 | 0 | 0 | |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Payment of Exercise | F | 210.10 | 2,016 | 423,562 | 18,237 | 20.3 K to 18.2 K (-9.95 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Grant | A | 0.00 | 3,925 | 0 | 20,253 | 16.3 K to 20.3 K (+24.04 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Payment of Exercise | F | 210.10 | 2,366 | 497,097 | 16,328 | 18.7 K to 16.3 K (-12.66 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Grant | A | 0.00 | 4,606 | 0 | 18,694 | 14.1 K to 18.7 K (+32.69 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Payment of Exercise | F | 217.79 | 542 | 118,042 | 14,088 | 14.6 K to 14.1 K (-3.70 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Grant | A | 0.00 | 1,055 | 0 | 14,630 | 13.6 K to 14.6 K (+7.77 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Payment of Exercise | F | 217.79 | 1,725 | 375,688 | 13,575 | 15.3 K to 13.6 K (-11.27 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Grant | A | 0.00 | 3,519 | 0 | 15,300 | 11.8 K to 15.3 K (+29.87 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Payment of Exercise | F | 210.10 | 824 | 173,122 | 7,812 | 8.6 K to 7.8 K (-9.54 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Grant | A | 0.00 | 1,661 | 0 | 8,636 | 7 K to 8.6 K (+23.81 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Payment of Exercise | F | 210.10 | 857 | 180,056 | 6,975 | 7.8 K to 7 K (-10.94 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Grant | A | 0.00 | 1,727 | 0 | 7,832 | 6.1 K to 7.8 K (+28.29 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Payment of Exercise | F | 210.10 | 824 | 173,122 | 7,310 | 8.1 K to 7.3 K (-10.13 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Grant | A | 0.00 | 1,661 | 0 | 8,134 | 6.5 K to 8.1 K (+25.66 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Payment of Exercise | F | 210.10 | 633 | 132,993 | 6,473 | 7.1 K to 6.5 K (-8.91 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Grant | A | 0.00 | 1,727 | 0 | 7,106 | 5.4 K to 7.1 K (+32.11 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,094 | 0 | 0 | |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Option Exercise | M | 0.00 | 3,646 | 0 | 0 | |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Payment of Exercise | F | 210.10 | 1,797 | 377,550 | 25,167 | 27 K to 25.2 K (-6.66 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Grant | A | 0.00 | 3,623 | 0 | 26,964 | 23.3 K to 27 K (+15.52 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Payment of Exercise | F | 210.10 | 2,284 | 479,868 | 23,341 | 25.6 K to 23.3 K (-8.91 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Grant | A | 0.00 | 4,606 | 0 | 25,625 | 21 K to 25.6 K (+21.91 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Payment of Exercise | F | 217.79 | 543 | 118,260 | 21,019 | 21.6 K to 21 K (-2.52 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Grant | A | 0.00 | 1,094 | 0 | 21,562 | 20.5 K to 21.6 K (+5.34 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Payment of Exercise | F | 217.79 | 1,723 | 375,252 | 20,468 | 22.2 K to 20.5 K (-7.76 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Grant | A | 0.00 | 3,646 | 0 | 22,191 | 18.5 K to 22.2 K (+19.66 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Option Exercise | M | 0.00 | 2,808 | 0 | 0 | |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Option Exercise | M | 0.00 | 9,363 | 0 | 0 | |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Payment of Exercise | F | 210.10 | 9,282 | 1,950,148 | 490,807 | 500.1 K to 490.8 K (-1.86 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Grant | A | 0.00 | 18,720 | 0 | 500,089 | 481.4 K to 500.1 K (+3.89 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Payment of Exercise | F | 210.10 | 6,851 | 1,439,395 | 481,369 | 488.2 K to 481.4 K (-1.40 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Grant | A | 0.00 | 13,818 | 0 | 488,220 | 474.4 K to 488.2 K (+2.91 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Payment of Exercise | F | 217.79 | 1,393 | 303,381 | 474,402 | 475.8 K to 474.4 K (-0.29 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Grant | A | 0.00 | 2,808 | 0 | 475,795 | 473 K to 475.8 K (+0.59 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Payment of Exercise | F | 217.79 | 4,423 | 963,285 | 472,987 | 477.4 K to 473 K (-0.93 %) |
| Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Grant | A | 0.00 | 9,363 | 0 | 477,410 | 468 K to 477.4 K (+2.00 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Option Exercise | M | 0.00 | 7,172 | 0 | 0 | |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Payment of Exercise | F | 227.97 | 3,470 | 791,056 | 21,978 | 25.4 K to 22 K (-13.64 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Grant | A | 0.00 | 7,172 | 0 | 25,448 | 18.3 K to 25.4 K (+39.24 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,594 | 0 | 0 | |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Payment of Exercise | F | 227.97 | 3,766 | 858,535 | 10,315 | 14.1 K to 10.3 K (-26.75 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Grant | A | 0.00 | 7,594 | 0 | 14,081 | 6.5 K to 14.1 K (+117.06 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Option Exercise | M | 0.00 | 675 | 0 | 0 | |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Payment of Exercise | F | 227.97 | 165 | 37,615 | 9,832 | 10 K to 9.8 K (-1.65 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Grant | A | 0.00 | 675 | 0 | 9,997 | 9.3 K to 10 K (+7.24 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 0.00 | 7,172 | 0 | 0 | |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Payment of Exercise | F | 227.97 | 3,683 | 839,614 | 11,781 | 15.5 K to 11.8 K (-23.82 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Grant | A | 0.00 | 7,172 | 0 | 15,464 | 8.3 K to 15.5 K (+86.49 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Option Exercise | M | 0.00 | 3,797 | 0 | 0 | |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Payment of Exercise | F | 227.97 | 1,883 | 429,268 | 6,105 | 8 K to 6.1 K (-23.57 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Grant | A | 0.00 | 3,797 | 0 | 7,988 | 4.2 K to 8 K (+90.60 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Option Exercise | M | 0.00 | 675 | 0 | 0 | |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Payment of Exercise | F | 227.97 | 234 | 53,345 | 5,379 | 5.6 K to 5.4 K (-4.17 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Grant | A | 0.00 | 675 | 0 | 5,613 | 4.9 K to 5.6 K (+13.67 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Option Exercise | M | 0.00 | 7,172 | 0 | 0 | |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Payment of Exercise | F | 227.97 | 3,556 | 810,661 | 18,545 | 22.1 K to 18.5 K (-16.09 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Grant | A | 0.00 | 7,172 | 0 | 22,101 | 14.9 K to 22.1 K (+48.04 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Option Exercise | M | 0.00 | 20,250 | 0 | 0 | |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Payment of Exercise | F | 227.97 | 10,040 | 2,288,819 | 468,047 | 478.1 K to 468 K (-2.10 %) |
| Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Grant | A | 0.00 | 20,250 | 0 | 478,087 | 457.8 K to 478.1 K (+4.42 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,616 | 0 | 11,232 | |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Payment of Exercise | F | 236.85 | 2,498 | 591,651 | 6,487 | 9 K to 6.5 K (-27.80 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Grant | A | 0.00 | 5,616 | 0 | 8,985 | 3.4 K to 9 K (+166.70 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Option Exercise | M | 0.00 | 1,661 | 0 | 4,980 | |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Payment of Exercise | F | 236.85 | 575 | 136,189 | 18,276 | 18.9 K to 18.3 K (-3.05 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Grant | A | 0.00 | 1,661 | 0 | 18,851 | 17.2 K to 18.9 K (+9.66 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Option Exercise | M | 0.00 | 593 | 0 | 1,779 | |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Payment of Exercise | F | 236.85 | 145 | 34,343 | 9,302 | 9.4 K to 9.3 K (-1.53 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Grant | A | 0.00 | 593 | 0 | 9,447 | 8.9 K to 9.4 K (+6.70 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 0.00 | 4,268 | 0 | 8,536 | |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Payment of Exercise | F | 228.68 | 2,192 | 501,267 | 8,225 | 10.4 K to 8.2 K (-21.04 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Grant | A | 0.00 | 4,268 | 0 | 10,417 | 6.1 K to 10.4 K (+69.41 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Option Exercise | M | 0.00 | 1,661 | 0 | 4,980 | |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Payment of Exercise | F | 236.85 | 824 | 195,164 | 4,151 | 5 K to 4.2 K (-16.56 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Grant | A | 0.00 | 1,661 | 0 | 4,975 | 3.3 K to 5 K (+50.12 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Option Exercise | M | 0.00 | 653 | 0 | 1,956 | |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Payment of Exercise | F | 236.85 | 226 | 53,528 | 4,888 | 5.1 K to 4.9 K (-4.42 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Grant | A | 0.00 | 653 | 0 | 5,114 | 4.5 K to 5.1 K (+14.64 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,661 | 0 | 4,980 | |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Payment of Exercise | F | 236.85 | 791 | 187,348 | 14,929 | 15.7 K to 14.9 K (-5.03 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Grant | A | 0.00 | 1,661 | 0 | 15,720 | 14.1 K to 15.7 K (+11.81 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Option Exercise | M | 0.00 | 3,795 | 0 | 11,385 | |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Payment of Exercise | F | 236.85 | 1,882 | 445,752 | 457,736 | 459.6 K to 457.7 K (-0.41 %) |
| Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Grant | A | 0.00 | 3,795 | 0 | 459,618 | 455.8 K to 459.6 K (+0.83 %) |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Option Exercise | A | 0.00 | 5,118 | 0 | 5,118 | |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Option Exercise | A | 254.00 | 1,892 | 480,568 | 1,892 | |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Option Exercise | A | 0.00 | 1,893 | 0 | 1,893 | |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Option Exercise | A | 254.00 | 1,892 | 480,568 | 1,892 | |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Option Exercise | A | 0.00 | 1,893 | 0 | 1,893 | |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | A | 0.00 | 3,937 | 0 | 3,937 | |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | Hodges Michelle A. | SVP, General Counse ... | Option Exercise | A | 254.00 | 1,892 | 480,568 | 1,892 | |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | Hodges Michelle A. | SVP, General Counse ... | Option Exercise | A | 0.00 | 1,893 | 0 | 1,893 | |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Option Exercise | A | 254.00 | 1,892 | 480,568 | 1,892 | |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Option Exercise | A | 0.00 | 1,893 | 0 | 1,893 | |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Option Exercise | A | 254.00 | 1,892 | 480,568 | 1,892 | |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Option Exercise | A | 0.00 | 1,893 | 0 | 1,893 | |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Option Exercise | A | 254.00 | 3,514 | 892,556 | 3,514 | |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Option Exercise | A | 0.00 | 3,516 | 0 | 3,516 | |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Option Exercise | A | 254.00 | 8,924 | 2,266,696 | 8,924 | |
| Feb 03 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Option Exercise | A | 0.00 | 4,462 | 0 | 4,462 | |
| Feb 02 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 0.00 | 2,970 | 0 | 0 | |
| Feb 02 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Payment of Exercise | F | 250.97 | 1,526 | 382,980 | 6,149 | 7.7 K to 6.1 K (-19.88 %) |
| Feb 02 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Grant | A | 0.00 | 2,970 | 0 | 7,675 | 4.7 K to 7.7 K (+63.12 %) |
| Feb 02 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Option Exercise | M | 0.00 | 2,970 | 0 | 0 | |
| Feb 02 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Payment of Exercise | F | 250.97 | 1,126 | 282,592 | 3,314 | 4.4 K to 3.3 K (-25.36 %) |
| Feb 02 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Grant | A | 0.00 | 2,970 | 0 | 4,440 | 1.5 K to 4.4 K (+202.04 %) |
| Feb 02 2021 | QDEL | QUIDEL CORP /DE/ | Abney Michael Donald Jr. | SVP - N.A. Sales & ... | Option Exercise | M | 0.00 | 2,970 | 0 | 0 | |
| Feb 02 2021 | QDEL | QUIDEL CORP /DE/ | Abney Michael Donald Jr. | SVP - N.A. Sales & ... | Payment of Exercise | F | 250.97 | 832 | 208,807 | 8,772 | 9.6 K to 8.8 K (-8.66 %) |
| Feb 02 2021 | QDEL | QUIDEL CORP /DE/ | Abney Michael Donald Jr. | SVP - N.A. Sales & ... | Grant | A | 0.00 | 2,970 | 0 | 9,604 | 6.6 K to 9.6 K (+44.77 %) |